ACN Q1 2026 Earnings Earnings Beat Expectations Amid Steady Consulting Demand Rockwell Medical Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges OFS Q1 2026 Earnings Staggering EPS Beat of 475 Surprises Market FTFT Q2 2024 Earnings Narrowing Losses Amidst Strategic Transformation in Blockchain and Fintech ACCO Q1 2026 Earnings EPS Surge Defies Expectations Passage Bio Inc PASG Edges Higher Testing Key Resistance Levels Diginex Limited DGNX Advances 488 to 129 Approaching Resistance at 135 MannKind Corporation MNKD Surges 44 Testing Key Resistance Amid Biotech Momentum Alto Ingredients ALTO Gains 377 as Stock Approaches Resistance Zone CBOE Q1 2026 Earnings EPS Surges Past Estimates on Strong Trading Activity